Welcoming New Faculty – Matthew Mossanen, MD, MPH

Please join us in welcoming Matthew Mossanen, MD, MPH, as a new faculty member in the Department of Surgery.

 

Matthew Mossanen, MD, MPH, Headshot
Matthew Mossanen, MD, MPH

 

Matthew Mossanen, MD, MPH
Associate Surgeon, Division of Urology, Brigham and Women’s Hospital

Dr. Mossanen is a graduate of the University of California, Los Angeles (UCLA) in Los Angeles, CA and received his medical degree from the David Geffen School of Medicine at UCLA. He also holds a Master of Public Health from the Harvard T.H. Chan School of Public Health in Boston, MA. Dr. Mossanen completed a residency in Urology from the University of Washington in Seattle, WA followed by a fellowship in Urologic Oncology in the Combined Harvard Urologic Oncology Fellowship at Massachusetts General Hospital and Brigham and Women’s Hospital.

His research and clinical interests include: benign prostatic hyperplasia, bladder cancer, kidney cancer, kidney masses/cysts, laparoscopic surgery, penile cancer, prostate cancer, robotic surgery and testicular cancer.

Welcoming New Faculty – Matthew D. Ingham, MD

Please join us in welcoming Matthew D. Ingham, MD, as a new faculty member in the Department of Surgery.

Matthew Ingham, MD, Headshot
Matthew D. Ingham, MD

Matthew D. Ingham, MD
Associate Surgeon, Division of Urology, Brigham and Women’s Hospital

Dr. Ingham is a graduate of the University of Toronto in Toronto, ON, Canada and received his medical degree from Eastern Virginia Medical School in Norfolk, VA. He completed a residency in Reconstructive Surgery and Pelvic Health, also at Eastern Virginia Medical School, followed by a fellowship in Urologic Oncology in the Combined Harvard Urologic Oncology Fellowship at Massachusetts General Hospital and Brigham and Women’s Hospital.

His research and clinical interests include: Benign prostatic hyperplasia, bladder cancer, hydronephrosis, kidney cancer, kidney masses/cysts, laparoscopic surgery, penile cancer, prostate cancer, robotic surgery and testicular cancer.